Case Report of Non–Small Cell Lung Cancer with STRN-ALK Translocation: A Nonresponder to Alectinib

Journal of Thoracic Oncology

Volumn 12, Issue 12, 2017, Pages e202-e204

  Nakanishi, Yoko ^a   Masuda, Shinobu ^a   Iida, Yuko ^a   Takahashi, Noriaki ^a   Hashimoto, Shu ^a  

^a NIHON UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALECTINIB; ANAPLASTIC LYMPHOMA KINASE; BINDING PROTEIN; DOCETAXEL; MULTIDRUG RESISTANCE PROTEIN 1; RNA; STRIATIN; UNCLASSIFIED DRUG; CARBAZOLE DERIVATIVE; PIPERIDINE DERIVATIVE; PROTEIN KINASE INHIBITOR;

ADULT; ALK GENE; CANCER MORTALITY; CANCER STAGING; CASE REPORT; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; GENE; GENE FUSION; GENE TRANSLOCATION; HUMAN; LEG PAIN; LETTER; LUNG EMBOLISM; LYMPH NODE BIOPSY; LYMPHADENOPATHY; MALE; MEDIASTINUM LYMPH NODE; MIDDLE AGED; NON SMALL CELL LUNG CANCER; PERICARDIAL EFFUSION; PLEURA EFFUSION; PRIORITY JOURNAL; RNA SEQUENCE; STRN GENE; SUPRACLAVICULAR LYMPH NODE; TREATMENT OUTCOME; TREATMENT RESPONSE; WALKING DIFFICULTY; GENETICS; LUNG TUMOR; PATHOLOGY;

CARBAZOLES; CARCINOMA, NON-SMALL-CELL LUNG; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; PIPERIDINES; PROTEIN KINASE INHIBITORS; TRANSLOCATION, GENETIC;

EID: 85034612059     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1016/j.jtho.2017.08.009     Document Type: Letter

References (5)

1. Gainor, J.F., Dardaei, L., Yoda, S., et al. Molecular mechanisms of resistance to first- and second-generation ALK inhibitors in ALK-rearranged lung cancer. Cancer Discov 6 (2016), 1118–1133.
2. Kelly, L.M., Barila, G., Liu, P., et al. Identification of the transforming STRN-ALK fusion as a potential therapeutic target in the aggressive forms of thyroid cancer. Proc Natl Acad Sci U S A 111 (2014), 4233–4238.
3. Yakirevich, E., Resnick, M.B., Mangray, S., et al. Oncogenic ALK fusion in rare and aggressive subtype of colorectal adenocarcinoma as a potential therapeutic target. Clin Cancer Res 22 (2016), 3831–3840.
4. Majewski, I.J., Mittempergher, L., Davidson, N.M., et al. Identification of recurrent FGFR3 fusion genes in lung cancer through kinome-centered RNA sequencing. J Pathol 23 (2013), 270–276.
5. Katayama, R., Sakashita, T., Yanagitani, N., et al. P-glycoprotein mediates ceritinib resistance in anaplastic lymphoma kinase-rearranged non-small cell lung cancer. EBioMedicine 3 (2015), 54–66.